Drug quality from a patient’s perspective
Importation a cliché, not a CAPA
Life and death and #BIO2017
No choice, no free market
Poverty, politics and preventable disease: Blurring the lines between truth and fiction in BioWorld’s 11th annual Summer Reading List
Scientists don’t do politics … until now
Myth busters take on drug prices, or do they?
Is ‘what the patient pays’ the right barometer for pricing drugs?
Yes, there’s a doctor in the House (and Senate)
Time for fa-la-la with BioWorld’s 10th annual Holiday Gift Guide

Pages